These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12496219)

  • 21. Late anaemia in Rh haemolytic disease.
    Ovalý F
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F444; author reply F445. PubMed ID: 12937058
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
    Mundy CA
    Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing face of haemolytic disease of the newborn.
    Roberts IA
    Early Hum Dev; 2008 Aug; 84(8):515-23. PubMed ID: 18621490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility.
    Sato K; Hara T; Kondo T; Iwao H; Honda S; Ueda K
    Acta Paediatr Scand; 1991 Feb; 80(2):163-6. PubMed ID: 1709770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [High-dose intravenous immunoglobulin therapy and neonatal jaundice due to red blood cell alloimmunization].
    Monpoux F; Dageville C; Maillotte AM; De Smet S; Casagrande F; Boutté P
    Arch Pediatr; 2009 Sep; 16(9):1289-94. PubMed ID: 19586760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility].
    Rübo J; Wahn V
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():104-8; discussion 109. PubMed ID: 8499737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemolytic disease of the newborn caused by rhesus isoimmunization (anti-c).
    Felc Z
    East Mediterr Health J; 2001 Nov; 7(6):1065-9. PubMed ID: 15332750
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
    Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
    Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemolytic disease of the newborn.
    Murray NA; Roberts IA
    Arch Dis Child Fetal Neonatal Ed; 2007 Mar; 92(2):F83-8. PubMed ID: 17337672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease.
    Alonso JG; Decaro J; Marrero A; Lavalle E; Martell M; Cuadro JC
    J Perinat Med; 1994; 22(5):415-9. PubMed ID: 7791017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABO haemolytic disease: sex ratio and blood groups in the newborns requiring treatment.
    Hodr R
    Czech Med; 1989; 12(3):125-33. PubMed ID: 2509171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of intravenous Ig and alterations in haematological parameters of infants with isoimmune haemolytic disease.
    Freyne B; O'Hare FM; Molloy EJ
    Arch Dis Child Fetal Neonatal Ed; 2012 Jan; 97(1):F76-7. PubMed ID: 22171016
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin in Rh hemolytic disease of newborn.
    Dutta S
    Indian Pediatr; 2009 Jan; 46(1):80-1; author reply 81. PubMed ID: 19179727
    [No Abstract]   [Full Text] [Related]  

  • 38. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2000; (2):CD001239. PubMed ID: 10796256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bloodless treatment of infants with haemolytic disease.
    Lakatos L
    Arch Dis Child; 2004 Nov; 89(11):1076. PubMed ID: 15499070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.